Ultragenyx Pharma (RARE) Upcoming Data Could Move Shares - Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Jeffrey Hung reiterated an Overweight rating and $83.00 price target on Ultragenyx Pharma (NASDAQ: RARE) ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
